Tango Therapeutics Inc.

TNGX | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.33

+$0.58 (+2.67%)

At close: Sep 21, 2026, 4:00 PM ET

$22.75

+$0.42 (+1.88%)

Pre-market: Sep 22, 2026, 5:53 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-101.59M	-130.3M	-101.74M	-108.18M	-58.24M	-51.97M
Depreciation & Amortization	2.28M	2.5M	2.42M	1.61M	897K	718K
Stock-Based Compensation	26.43M	28.9M	19.08M	14.23M	7.83M	1.76M
Other Working Capital	-66.37M	-30.56M	-38.26M	-19.59M	-12.58M	119.5M
Other Non-Cash Items	1.2M	-849K	234K	1.75M	1.32M	890K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-67.2M	-31.75M	-37.97M	-18.49M	-11.35M	118.67M
Operating Cash Flow	-138.89M	-131.5M	-117.98M	-109.08M	-59.53M	70.07M
Capital Expenditures	-1.05M	-754K	-1.53M	-7.69M	-1.84M	-1.11M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-264.46M	-240.89M	-310.57M	-208.5M	-372.36M	-207.54M
Sales Maturities Of Investments	224.64M	327.77M	353.53M	242.6M	190.76M	63.22M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	-40K
Investing Cash Flow	-40.87M	86.13M	41.43M	26.4M	-183.43M	-145.47M
Debt Repayment	n/a	n/a	n/a	n/a	342.11M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-36K	5.94M	2.39M	1.62M	-14.78M	40K
Financial Cash Flow	222.5M	47.66M	82.41M	1.62M	357.33M	80.88M
Net Cash Flow	42.75M	2.29M	5.85M	-81.07M	114.36M	5.49M
Free Cash Flow	-139.93M	-132.26M	-119.51M	-116.77M	-61.36M	68.97M
Adj. Free Cash Flow	-166.36M	-161.15M	-138.59M	-131M	-69.2M	67.2M
Maintenance CapEx	n/a	n/a	n/a	-7.69M	n/a	-1.11M
Growth CapEx	-1.05M	-754K	-1.53M	n/a	-1.84M	n/a
Owner Earnings	-138.89M	-131.5M	-117.98M	-116.77M	-59.53M	68.97M